Qube Research & Technologies (QRT)
EIDX

Qube Research & Technologies (QRT)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,982
Closed -$3.42M – 2629
2020
Q4 		$3.42M Buy
+25,982
New +$2.3M 0.05% 425
2020
Q1 		– Sell
-4,900
Closed -$281K – 1864
2019
Q4 		$281K Buy
+4,900
New +$243K 0.01% 1247

Qube Research & Technologies (QRT)'s EIDX Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 25,982 shares — an estimated $3.42M sold.

Qube Research & Technologies (QRT) first reported a position in EIDX in Q4 2019 and held it in 2 quarters. The position peaked at $3.42M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 25,982 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $3.42M.
  • Qube Research & Technologies (QRT) first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Eidos Therapeutics, Inc. Common Stock position peaked at $3.42M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.